Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Drug's journey through the body under the microscope

NCT ID NCT07466550

Not yet recruiting Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

Summary

This study aims to understand how the drug risankizumab is processed by the body when given in two different ways: as an injection under the skin and as an infusion into a vein. It will involve 60 healthy volunteers. The main goal is to measure the drug's levels in the blood and track any side effects to see how the body handles it.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.